| Prev Close | 160.50 |
| Open | 161.67 |
| Day Low/High | 160.73 / 165.91 |
| 52 Wk Low/High | 93.56 / 263.47 |
| Volume | 2.72M |
Teladoc Health, Inc. (TDOC)
163.27
2.77
1.73
NYSE
| Exchange | NYSE |
| Shares Outstanding | 154.53B |
| Market Cap | 24.36B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
I'm Not Buying This Rally
Buy I am buying SPDR S&P 500 exchange-traded fund puts -- here's how.
Jim Cramer: Let Me Explain How Good Companies Can Have Bad Stocks
Here's a lesson I learned decades ago at Goldman Sachs about how stocks can move in times like this.
The Trade Desk: Another Unhappy Ending for Momentum Traders?
Like other momentum stocks, the provider of software to manage digital ad campaigns traded way over its skis and suddenly finds itself tumbling.
I Stopped Believing in ARKK Months Ago
* Here's why ARK Invest's holdings are impacting the Nasdaq * ARKK weakness - and the attendant sales of its largest positions - may augur poorly for the Nasdaq in the weeks ahead "Just a small town girl Livin' in a lonely world She took the midnig...
5 Takeaways From an Eventful Tech Earnings Season
Among other things, results revealed that quite a few firms are now facing a higher bar, and that reopenings have begun affecting consumer behavior in a number of ways.
The Doctor Is in, Teladoc Is Out
Roll up your sleeve and know this might hurt a bit: The charts of TDOC show prices are pointed ... lower.
I Gotta Tell Ya...
Watch and some of its constituent positions - , , , , etc. Not good. My short thesis on the name seems ever more compelling - with the nail on the ARK Invest perhaps an exodus of investors as outflows begin to rise/mount.
Earnings Avalanche, FOMC, Growth and Inflation, Biden's Spending Plans
The US Ten Year Note has been on the move, and the US Dollar Index has also been climbing overnight.
Here's My Reply to a Subscriber Who Asked About the ARK Innovation ETF
ARKK has produced impressive gains but it looks like it is still in a correction phase. Here's what aggressive traders could do.
The Doctor Found Something Amiss on the Charts of Teladoc
The name appears bearish and risky right now.
Are ViacomCBS and Discovery Worth a Look After Their Big Slides?
The answer is yes for one of the two stocks that sold off sharply due to forced liquidations by a big shareholder.
Jim Cramer: The Do's and Don'ts to Survive This Market
You need to respect that a market can be as vicious and nasty as it was joyous and oblivious toward the news that comes its way.
Here's Why I'm Selling Teladoc Health
Volume has picked up dramatically since a selloff in the online health services provider began, and it could get worse.
Hall of Mirrors, Connecting the Fed Dots, National Debt Q&A, Amazon Disrupts
As a very wise man once said: 'I'll gladly pay you Tuesday for a hamburger today.'
I Like the Growth Prospects for TeleHealth Stock LifeMD
Since we don't have a breakout, I would stay with a half-size approach on any trade here.
Tuesday's Wild Ride, Jay Powell, Borrowing Concerns, Palantir, Trading Nvidia
The Fed Chair threaded the needle better than Joe Montana down by six with a minute to go on any given Sunday.
Just Had My First Teladoc Appointment: Is the Rally Over?
I may be late to trends, but not to stock charts.
Jim Cramer: What's Winning Is the Technology of Replacement
If you look at the economy as between service and tech you find the old-guard being overrun.
Jim Cramer: There's Good Risk and Bad Risk
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
Telehealth Isn't Just for People Anymore
A look at the fast-growing field of telehealth, both for people and, as a less-well known market, for pets.
Teladoc's Charts Are Bearish - Avoid the Long Side for Now
Prices have broken the lows of August and September so the trend has turned down.
Teladoc Could Rally From Here
Is Teladoc's merger with Livongo Health a 'game changer' for the stock?
Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks
The 'work from home' or 'economic lockdown' trade is close to being back on.
Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
